← Back to Search

Hemostatic Agent

Hemospray Treatment for Peptic Ulcer (HALT Trial)

N/A
Waitlist Available
Research Sponsored by Cook Group Incorporated
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Bleeding peptic ulcer
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

The objective of this study is to show that Hemospray is effective in achieving initial hemostasis and documenting rate of further bleed when compared to standard of care.

Eligible Conditions
  • Peptic Ulcer

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Hemospray TreatmentExperimental Treatment1 Intervention
Hemospray Kit
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Hemospray Kit
2011
N/A
~70

Find a Location

Who is running the clinical trial?

Cook Group IncorporatedLead Sponsor
91 Previous Clinical Trials
15,445 Total Patients Enrolled
~5 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top